Syncom Formulations (India) Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 544.91 million compared to INR 529.37 million a year ago. Revenue was INR 573.63 million compared to INR 556.62 million a year ago. Net income was INR 35.92 million compared to INR 56.22 million a year ago. Basic earnings per share from continuing operations was INR 0.06 compared to INR 0.06 a year ago. Diluted earnings per share from continuing operations was INR 0.06 compared to INR 0.06 a year ago.
For the six months, sales was INR 1,058.92 million compared to INR 1,042.06 million a year ago. Revenue was INR 1,117.43 million compared to INR 1,082.62 million a year ago. Net income was INR 74.59 million compared to INR 110.19 million a year ago. Basic earnings per share from continuing operations was INR 0.09 compared to INR 0.14 a year ago. Diluted earnings per share from continuing operations was INR 0.09 compared to INR 0.13 a year ago.